Page 332 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 332
Genetic and Pediatric Liver Diseases (Cont.)

TOP 10% FUNCTIONAL CHARACTERIZATION AND DRUG RESPONSE
YI P1232 TO ZINC AND D-PENICILLAMINE OF DISEASE-CAUSING
ATP7B MUTATIONS IN A HUMAN HEPATOMA CELL LINE
Gursimran Chandhok*, Vanessa Sauer, Christoph Niemietz,
Andree Zibert, Hartmut H.-J. Schmidt, Germany 

TOP 10% RETARGETING OF BILE SALT EXPORT PUMP (BSEP) AND
YI P1233 CRITERIA OF FAVOURABLE OUTCOME IN CHILDRENWITH
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASISTYPE
II (PFIC-II)
Sharat Varma*, Nicole Revencu, Xavier Stephenne, Isabelle Scheers,
Francoise Smets, Ana Beleza, Catherine de Magnée, Raymond Reding,
Tania Roskams, Etienne Sokal, Belgium

YI P1234 LOW HEPCIDIN/FERRITIN RATIO IN C282Y HOMOZYGOTES
CORRELATES INVERSELY WITH TRANSFERRIN
ePOSTERS SATURATION AND NON-TRANSFERRIN BOUND IRON
LEVELS
John D. Ryan*, Eleanor Ryan, Jennifer Russell, Barbara Coughlan,
Harold Tjalsma, Dorine W. Swinkels, Stephen Stewart, John Crowe,
The United Kingdom

YI P1235 HEREDITARY HEMOCHROMATOSIS: ROLE OF H63D
HOMOZYGOSITY IN HEPATIC IRON OVERLOAD
Rosa M. Martin Mateos*, Javier Graus Morales, Dolores Rey Zamora,
Víctor F. Moreira Vicente, Agustín Albillos, Daniel Boixeda de Miquel,
Spain

YI P1236 IMPACT OF HIGH PORTAL PRESSURE ON RENAL
HEMODYNAMICS IN CHILDREN WITH PORTAL
HYPERTENSION
Rustam  Z. Yuldashev*, Makhmud M. Aliev, Gulnora S. Adilova,
Uzbekistan 

YI P1237 THE MODIFIED IRON AVIDITY INDEX: A
PROMISING PHENOTYPICAL PREDICTOR IN HFE-
HAEMOCHROMATOSIS
Pauline Verhaegh*, Wenke Moris, Cees van Deursen, Ger Koek,
The Netherlands

332 The International Liver Congress™ 2015 • ILC Programme
   327   328   329   330   331   332   333   334   335   336   337